- Home
- AUUD vs INM Comparison
AUUD vs INM Comparison
Compare AUUD & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- INM
- Stock Information
- Founded
- AUUD 2012
- INM 1981
- Country
- AUUD United States
- INM Canada
- Employees
- AUUD N/A
- INM N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- INM Health Care
- Exchange
- AUUD Nasdaq
- INM Nasdaq
- Market Cap
- AUUD 3.1M
- INM 3.4M
- IPO Year
- AUUD 2021
- INM N/A
- Fundamental
- Price
- AUUD $0.49
- INM $4.95
- Analyst Decision
- AUUD
- INM
- Analyst Count
- AUUD 0
- INM 0
- Target Price
- AUUD N/A
- INM N/A
- AVG Volume (30 Days)
- AUUD 1.2M
- INM 26.6K
- Earning Date
- AUUD 11-07-2024
- INM 02-11-2025
- Dividend Yield
- AUUD N/A
- INM N/A
- EPS Growth
- AUUD N/A
- INM N/A
- EPS
- AUUD N/A
- INM N/A
- Revenue
- AUUD N/A
- INM $4,960,506.00
- Revenue This Year
- AUUD N/A
- INM N/A
- Revenue Next Year
- AUUD N/A
- INM N/A
- P/E Ratio
- AUUD N/A
- INM N/A
- Revenue Growth
- AUUD N/A
- INM 5.17
- 52 Week Low
- AUUD $0.43
- INM $2.42
- 52 Week High
- AUUD $11.75
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- AUUD 43.62
- INM 55.90
- Support Level
- AUUD $0.46
- INM $4.07
- Resistance Level
- AUUD $0.61
- INM $5.41
- Average True Range (ATR)
- AUUD 0.05
- INM 0.39
- MACD
- AUUD -0.00
- INM 0.01
- Stochastic Oscillator
- AUUD 19.74
- INM 67.83
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products include Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.